51 results
8-K
EX-99.1
VTRO
Vitro Biopharma, Inc.
22 Jan 24
Vitro Biopharma Announces New Chief Financial Officer
9:17pm
of regenerative medicine and cellular therapies, with ancillary focuses in the research services and cosmeceuticals. With respect to our regenerative
10-12G/A
yt1p g1w1
21 Dec 22
Registration of securities (amended)
4:50pm
10-12G/A
i8bwtcv
4 Nov 22
Registration of securities (amended)
3:29pm
S-1/A
j8v0ne fhxg
3 Nov 22
IPO registration (amended)
5:28pm
10-12G
EX-99.1
7vke fjvtptxhw10og
9 Sep 22
Registration of securities
9:46pm
S-1
d7x9k8v4q
9 Sep 22
IPO registration
5:13pm
S-1
EX-24
kgmrdpyij7zox8xoa
9 Sep 22
IPO registration
5:13pm
8-K
EX-99.1
hzhviu1 q8uj5
5 Oct 20
Vitro Biopharma 3rd Quarter ended July 31st 2020 Financial Results of Operations
5:20pm
8-K
EX-99.1
oy6av3kb5
9 Jul 20
Vitro Biopharma 2nd Quarter ended April 30th 2020 Financial Results of Operations
12:23pm